As of June 6, 2025, Zhejiang Canaan Technology Ltd (300412.SZ) reports a Gross Margin of 23.64%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Zhejiang Canaan Technology Ltd's Gross Margin
Over recent years, Zhejiang Canaan Technology Ltd's Gross Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-12-31 | 23.64% |
| 2023-12-31 | 25.71% |
| 2022-12-31 | 22.94% |
| 2021-12-31 | 28.63% |
| 2020-12-31 | 28.53% |
This gradual decrease highlights how Zhejiang Canaan Technology Ltd manages its operational efficiency and pricing power over time.
Comparing Zhejiang Canaan Technology Ltd's Gross Margin to Peers
To better understand Zhejiang Canaan Technology Ltd's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Zhejiang Canaan Technology Ltd (300412.SZ) | 23.64% |
| Shanghai Sanyou Medical Co Ltd (688085.SS) | 77.45% |
| Beijing Chunlizhengda Medical Instruments Co Ltd (1858.HK) | 72.58% |
| Andon Health Co Ltd (002432.SZ) | 69.72% |
| Jiangsu Apon Medical Technology Co Ltd (300753.SZ) | 68.37% |
| Guangzhou LBP Medicine Science & Technology Co Ltd (688393.SS) | 67.65% |
Compared to its competitors, Zhejiang Canaan Technology Ltd's Gross Margin is among the lowest compared to peers, suggesting potential challenges in production costs or pricing strategy.